NL1012517C2 - Deeltjes, in het bijzonder microdeeltjes of nanodeeltjes van dwarsverbonden monosacchariden en oligosacchariden, werkwijze voor het bereiden hiervan en cosmetische, farmaceutische of levensmiddelen samenstellingen waarin deze aanwezig zijn. - Google Patents
Deeltjes, in het bijzonder microdeeltjes of nanodeeltjes van dwarsverbonden monosacchariden en oligosacchariden, werkwijze voor het bereiden hiervan en cosmetische, farmaceutische of levensmiddelen samenstellingen waarin deze aanwezig zijn. Download PDFInfo
- Publication number
- NL1012517C2 NL1012517C2 NL1012517A NL1012517A NL1012517C2 NL 1012517 C2 NL1012517 C2 NL 1012517C2 NL 1012517 A NL1012517 A NL 1012517A NL 1012517 A NL1012517 A NL 1012517A NL 1012517 C2 NL1012517 C2 NL 1012517C2
- Authority
- NL
- Netherlands
- Prior art keywords
- particles
- cross
- linked
- cyclodextrin
- cyclodextrins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
- A61Q1/04—Preparations containing skin colorants, e.g. pigments for lips
- A61Q1/06—Lipsticks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
- A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
- Y10S977/775—Nanosized powder or flake, e.g. nanosized catalyst
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/788—Of specified organic or carbon-based composition
- Y10S977/795—Composed of biological material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- General Chemical & Material Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Cosmetics (AREA)
- General Preparation And Processing Of Foods (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9808809A FR2780901B1 (fr) | 1998-07-09 | 1998-07-09 | Particules, en particulier micro- ou nanoparticules de monosaccharides et oligosaccharides reticules, leurs procedes de preparation et compositions cosmetiques, pharmaceutiques ou alimentaires en contenant |
FR9808809 | 1998-07-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
NL1012517C2 true NL1012517C2 (nl) | 2000-01-11 |
Family
ID=9528466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL1012517A NL1012517C2 (nl) | 1998-07-09 | 1999-07-05 | Deeltjes, in het bijzonder microdeeltjes of nanodeeltjes van dwarsverbonden monosacchariden en oligosacchariden, werkwijze voor het bereiden hiervan en cosmetische, farmaceutische of levensmiddelen samenstellingen waarin deze aanwezig zijn. |
Country Status (8)
Country | Link |
---|---|
US (1) | US6197757B1 (fr) |
JP (1) | JP3437797B2 (fr) |
KR (1) | KR100799407B1 (fr) |
DE (1) | DE19932216B4 (fr) |
ES (1) | ES2155793B1 (fr) |
FR (1) | FR2780901B1 (fr) |
IT (1) | IT1311514B1 (fr) |
NL (1) | NL1012517C2 (fr) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL1010926C2 (nl) * | 1998-12-30 | 2000-07-03 | Inst Voor Agrotech Onderzoek | Werkwijze voor de bereiding van zetmeeldeeltjes. |
US20020064801A1 (en) * | 1999-12-01 | 2002-05-30 | Ryan Jeffrey R. | Novel and practical serological assay for the clinical diagnosis of leishmaniasis |
US7758888B2 (en) | 2000-04-21 | 2010-07-20 | Sol-Gel Technologies Ltd. | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
US6607784B2 (en) * | 2000-12-22 | 2003-08-19 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
US8067032B2 (en) | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
US20050048126A1 (en) * | 2000-12-22 | 2005-03-03 | Barrett Rabinow | Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
US9700866B2 (en) * | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
US20040256749A1 (en) * | 2000-12-22 | 2004-12-23 | Mahesh Chaubal | Process for production of essentially solvent-free small particles |
US20030096013A1 (en) * | 2000-12-22 | 2003-05-22 | Jane Werling | Preparation of submicron sized particles with polymorph control |
US6884436B2 (en) * | 2000-12-22 | 2005-04-26 | Baxter International Inc. | Method for preparing submicron particle suspensions |
US7193084B2 (en) * | 2000-12-22 | 2007-03-20 | Baxter International Inc. | Polymorphic form of itraconazole |
FR2824756B1 (fr) * | 2001-05-16 | 2005-07-08 | Mainelab | Microcapsules a base de proteines vegetales |
KR100483193B1 (ko) * | 2001-06-05 | 2005-04-14 | 꼴레띠까 | 처리된 비수용성 고체 미립자, 그 미립자의 제조 및 사용법 |
FR2825293B1 (fr) * | 2001-06-05 | 2004-05-07 | Coletica | Particules solides insolubles dans l'eau traitees, preparation et utilisation |
US20060003012A9 (en) | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
AU2002337692B2 (en) * | 2001-09-26 | 2007-09-13 | Baxter International Inc. | Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal |
US20050227911A1 (en) * | 2001-09-28 | 2005-10-13 | Solubest Ltd. | Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules |
US6878693B2 (en) | 2001-09-28 | 2005-04-12 | Solubest Ltd. | Hydrophilic complexes of lipophilic materials and an apparatus and method for their production |
US20050233003A1 (en) * | 2001-09-28 | 2005-10-20 | Solubest Ltd. | Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid |
US7112340B2 (en) * | 2001-10-19 | 2006-09-26 | Baxter International Inc. | Compositions of and method for preparing stable particles in a frozen aqueous matrix |
US20030084914A1 (en) * | 2001-11-08 | 2003-05-08 | L'oreal | Cosmetic articles having encapsulated liquid and method of making same |
US7700851B2 (en) * | 2001-11-13 | 2010-04-20 | U.S. Smokeless Tobacco Company | Tobacco nicotine demethylase genomic clone and uses thereof |
FR2832632B1 (fr) | 2001-11-26 | 2004-04-23 | Mane Fils V | Capsule a solubilisation et liberation du contenu rapides |
US7714006B1 (en) | 2001-12-03 | 2010-05-11 | King Pharmaceuticals Research & Development, Inc. | Methods of modifying the bioavailability of metaxalone |
US6407128B1 (en) | 2001-12-03 | 2002-06-18 | Elan Pharmaceuticals, Inc. | Method for increasing the bioavailability of metaxalone |
FR2847163B1 (fr) * | 2002-11-19 | 2006-07-28 | Jean Claude Epiphani | Procede d'hydrosolubilisation d'un parfum et solution obtenue par le procede |
FR2848847B1 (fr) * | 2002-12-18 | 2005-10-14 | Coletica | Composition cosmetique ou dermopharmaceutique comprenant une enzyme insoluble en milieu aqueux, ainsi que ses utilisations |
FR2848854B1 (fr) * | 2002-12-24 | 2005-03-18 | Coletica | Particules comprenant un biopolymere degradable sous l'effet d'une onde electromagnetique telle qu'emise par un rayonnement solaire |
FR2850040B1 (fr) * | 2003-01-20 | 2005-03-11 | Centre Nat Rech Scient | Systemes pour microencapsulation et leurs applications |
US7923030B2 (en) | 2003-03-14 | 2011-04-12 | Sol-Gel Technologies, Inc. | Agent-encapsulating micro- and nanoparticles, methods for preparation of same and products containing same |
DE10315538A1 (de) * | 2003-04-04 | 2004-10-21 | Siemens Ag | Teilchen mit einer Membran |
JP2007508240A (ja) * | 2003-07-22 | 2007-04-05 | バクスター・インターナショナル・インコーポレイテッド | 低分子量有機分子の小球状粒子ならびにその調製方法および使用方法 |
EP1504664A1 (fr) * | 2003-07-29 | 2005-02-09 | Novartis AG | Composes organiques |
US8110284B2 (en) | 2003-07-31 | 2012-02-07 | Sol-Gel Technologies Ltd. | Microcapsules loaded with active ingredients and a method for their preparation |
WO2005055947A2 (fr) * | 2003-12-08 | 2005-06-23 | Yu Ruey J | Optimisation d'organes et de sites cutaneo-muqueux ou cutanes au moyen de compositions topiques |
WO2005060610A2 (fr) * | 2003-12-11 | 2005-07-07 | The Trustees Of Columbia University In The City Ofnew York | Particules a taille nanometrique, leurs procedes d'obtention, compositions et leurs utilisations |
US8241655B2 (en) * | 2004-05-12 | 2012-08-14 | Surmodics, Inc. | Coatings for medical articles including natural biodegradable polysaccharides |
US7282194B2 (en) * | 2004-10-05 | 2007-10-16 | Gp Medical, Inc. | Nanoparticles for protein drug delivery |
FR2882366B1 (fr) | 2005-02-18 | 2008-04-18 | Coletica Sa | Polymere reticule de carbohydrate, notamment a base de polysaccharides et/ou de polyols |
GB2423252B (en) * | 2005-02-18 | 2007-10-17 | Engelhard Lyon | Cross-linked polymer of carbohydrate, notably based on polysaccharides, and/or on oligosaccharides and/or on polyols |
CA2608930A1 (fr) * | 2005-06-14 | 2006-12-28 | Baxter International Inc. | Preparations pharmaceutiques permettant de reduire les interactions entre medicaments |
US20060280787A1 (en) * | 2005-06-14 | 2006-12-14 | Baxter International Inc. | Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof |
TWI342880B (en) * | 2005-07-19 | 2011-06-01 | Otsuka Chemical Co Ltd | Method for producing sugar chain derivatives, and sugar chain derivatives |
WO2007015243A2 (fr) | 2005-08-02 | 2007-02-08 | Sol-Gel Technologies Ltd. | Revetement par un oxyde metallique d'ingredients hydroinsolubles |
RU2313538C2 (ru) * | 2005-08-04 | 2007-12-27 | Борис Олегович Майер | Хитозановый продукт, способ его получения (варианты) |
GB0516761D0 (en) * | 2005-08-16 | 2005-09-21 | Eastman Kodak Co | Particulate polymeric material |
US8241656B2 (en) * | 2005-09-21 | 2012-08-14 | Surmodics, Inc | Articles including natural biodegradable polysaccharides and uses thereof |
WO2007038126A1 (fr) * | 2005-09-21 | 2007-04-05 | Surmodics, Inc. | Matrices formees in vivo contenant des polysaccharides biodegradables naturels et leurs utilisations ophtalmiques |
CA2628630A1 (fr) * | 2005-11-15 | 2007-05-24 | Baxter International Inc. | Compositions d'inhibiteurs de lipoxygenase |
US20070281031A1 (en) * | 2006-06-01 | 2007-12-06 | Guohan Yang | Microparticles and methods for production thereof |
JP5694664B2 (ja) * | 2006-09-29 | 2015-04-01 | サーモディクス,インコーポレイティド | 生分解性眼用インプラント及び眼の病気を治療する方法 |
US20090297626A1 (en) * | 2006-11-03 | 2009-12-03 | The Trustees Of Columbia University In The City Of New York | Methods for preparing metal oxides |
US20080154241A1 (en) * | 2006-12-07 | 2008-06-26 | Burkstrand Michael J | Latent stabilization of bioactive agents releasable from implantable medical articles |
US20090152176A1 (en) * | 2006-12-23 | 2009-06-18 | Baxter International Inc. | Magnetic separation of fine particles from compositions |
KR20090121291A (ko) * | 2007-02-01 | 2009-11-25 | 솔-겔 테크놀로지스 리미티드 | 산화금속 코팅을 포함한 입자의 제조방법 및 산화금속 코팅을 포함한 입자 |
ES2912051T3 (es) | 2007-02-01 | 2022-05-24 | Sol Gel Tech Ltd | Composiciones para aplicación tópica que comprenden un peróxido y retinoide |
US8426467B2 (en) * | 2007-05-22 | 2013-04-23 | Baxter International Inc. | Colored esmolol concentrate |
US8722736B2 (en) * | 2007-05-22 | 2014-05-13 | Baxter International Inc. | Multi-dose concentrate esmolol with benzyl alcohol |
US20080293814A1 (en) * | 2007-05-22 | 2008-11-27 | Deepak Tiwari | Concentrate esmolol |
CA2723192A1 (fr) * | 2008-05-07 | 2009-11-12 | Surmodics, Inc. | Administration de complexe d'acide nucleique a partir de particules |
US11458105B2 (en) | 2008-12-04 | 2022-10-04 | International Flavors & Fragrances Inc. | Hybrid fragrance encapsulate formulation and method for using the same |
US9763861B2 (en) | 2008-12-04 | 2017-09-19 | International Flavors & Fragrances Inc. | Stable, flowable silica capsule formulation |
US8901092B2 (en) | 2010-12-29 | 2014-12-02 | Surmodics, Inc. | Functionalized polysaccharides for active agent delivery |
EP2500087B1 (fr) | 2011-03-18 | 2018-10-10 | International Flavors & Fragrances Inc. | Microcapsules produites à partir de précurseurs mélangés de sol-gel |
ITTO20110372A1 (it) * | 2011-04-28 | 2012-10-29 | Univ Degli Studi Torino | Metodo per la preparazione di nanospugne di destrine |
US9687465B2 (en) | 2012-11-27 | 2017-06-27 | Sol-Gel Technologies Ltd. | Compositions for the treatment of rosacea |
US9056208B2 (en) * | 2013-02-07 | 2015-06-16 | Conopco Inc. | Personal care compositions that include enrobed sugar |
WO2015035245A1 (fr) | 2013-09-06 | 2015-03-12 | The Regents Of The University Of California | Particules d'oxyde métallique dotées de revêtements polymères multicouches uniformes |
KR101965319B1 (ko) * | 2015-08-24 | 2019-04-04 | 샨시 야바오 헬스 프로덕츠 컴퍼니 리미티드 | 항종양 약물 제조에서의 다이하이드록시아세톤의 용도 |
KR101762011B1 (ko) | 2015-09-02 | 2017-07-26 | 최화숙 | 3중매트릭스캡슐화가 가능한 화장료 조성물 및 이의 제조방법 |
CN106349396A (zh) * | 2016-08-26 | 2017-01-25 | 湖南尔康制药股份有限公司 | 一种具有超声敏感性的交联淀粉 |
LT3681475T (lt) * | 2017-10-16 | 2021-02-25 | Faes Farma, S.A. | Vandeninės kompozicijos, apimančios bilastiną ir mometazoną |
WO2021243188A1 (fr) * | 2020-05-29 | 2021-12-02 | Hemp Synergistics | Huile de cannabis en poudre |
KR20240015891A (ko) | 2022-07-28 | 2024-02-06 | 주식회사 수안향장 | 이중 매트릭스 캡슐의 제조방법 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3472835A (en) * | 1964-02-12 | 1969-10-14 | American Mach & Foundry | Schardinger dextrins |
US4774329A (en) * | 1987-08-04 | 1988-09-27 | American Maize-Products Company | Controlled release agent for cetylpyridinium chloride |
US4902788A (en) * | 1988-09-29 | 1990-02-20 | Uop | Crosslinked cyclodextrins supported on porous refractory inorganic oxides |
US4958015A (en) * | 1988-09-30 | 1990-09-18 | Uop | Preparation of crosslinked cyclodextrin resins with enhanced porosity |
US5395620A (en) * | 1989-01-31 | 1995-03-07 | Coletica | Biodegradable microcapsules having walls composed of crosslinked atelocollagen and polyholoside |
CA2042529C (fr) * | 1990-08-10 | 2002-07-30 | Chokyun Rha | Article contenant de la polysaccharide et ses utilisations |
ES2103947T5 (es) * | 1991-06-03 | 2001-05-16 | Nycomed Imaging As | Mejoras introducidas en o relacionadas con agentes de contraste. |
JPH0778126B2 (ja) * | 1992-02-10 | 1995-08-23 | 日清紡績株式会社 | 多糖類真球状粒子及び製造方法 |
FR2688422A1 (fr) * | 1992-03-11 | 1993-09-17 | Coletica | Microcapsules a parois en polysaccharides contenant des fonctions alcools primaires, et compositions en contenant. |
US5321064A (en) * | 1992-05-12 | 1994-06-14 | Regents Of The University Of Minnesota | Compositions of biodegradable natural and synthetic polymers |
SE470353B (sv) * | 1992-06-22 | 1994-01-31 | Volvo Penta Ab | Båtpropellerdrev med automatiskt trimorgan |
DK103393D0 (da) * | 1993-09-15 | 1993-09-15 | Ferrosan As | Praeparat |
-
1998
- 1998-07-09 FR FR9808809A patent/FR2780901B1/fr not_active Expired - Lifetime
-
1999
- 1999-07-05 NL NL1012517A patent/NL1012517C2/nl not_active IP Right Cessation
- 1999-07-08 KR KR19990027476A patent/KR100799407B1/ko not_active IP Right Cessation
- 1999-07-09 DE DE19932216A patent/DE19932216B4/de not_active Expired - Fee Related
- 1999-07-09 ES ES009901547A patent/ES2155793B1/es not_active Expired - Lifetime
- 1999-07-09 IT IT1999TO000599A patent/IT1311514B1/it active
- 1999-07-09 US US09/350,131 patent/US6197757B1/en not_active Expired - Lifetime
- 1999-07-09 JP JP19670599A patent/JP3437797B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IT1311514B1 (it) | 2002-03-13 |
DE19932216A1 (de) | 2000-01-27 |
JP3437797B2 (ja) | 2003-08-18 |
ES2155793A1 (es) | 2001-05-16 |
US6197757B1 (en) | 2001-03-06 |
FR2780901A1 (fr) | 2000-01-14 |
DE19932216B4 (de) | 2005-12-08 |
KR100799407B1 (ko) | 2008-01-30 |
ES2155793B1 (es) | 2001-12-01 |
FR2780901B1 (fr) | 2000-09-29 |
JP2000038402A (ja) | 2000-02-08 |
ITTO990599A1 (it) | 2001-01-09 |
KR20000011579A (ko) | 2000-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL1012517C2 (nl) | Deeltjes, in het bijzonder microdeeltjes of nanodeeltjes van dwarsverbonden monosacchariden en oligosacchariden, werkwijze voor het bereiden hiervan en cosmetische, farmaceutische of levensmiddelen samenstellingen waarin deze aanwezig zijn. | |
US6395302B1 (en) | Method for the preparation of microspheres which contain colloidal systems | |
US5961990A (en) | Cosmetic particulate gel delivery system and method of preparing complex gel particles | |
BRPI0613234A2 (pt) | sistema que inclui nanopartìculas para a libertação de moléculas biologicamente ativas, composição farmacêutica, composição cosmética, vacina, procedimento para obtenção de um sistema para a libertação controlada de molécula biologicamente ativa, procedimento para a obtenção de nanopartìculas e utilização de um sistema | |
TW200938208A (en) | Crosslinked hyaluronic acid in emulsion | |
WO2019139380A1 (fr) | Charge de microsphères de polycaprolactone contenant de la vitamine c et son procédé de préparation | |
BR112015009105B1 (pt) | Esfera, composição cosmética ou dermatológica para administração tópica, processo para sintetizar uma esfera, e, uso de uma esfera | |
CN116546979A (zh) | 包含胶囊的化妆品组合物 | |
Choudhury et al. | Liposome: a carrier for effective drug delivery | |
JP2010150151A (ja) | ヒアルロン酸担持ナノ粒子及びヒアルロン酸含有複合粒子並びにそれらを用いた化粧料 | |
FR2850040A1 (fr) | Systemes pour microencapsulation et leurs applications | |
CA3108431A1 (fr) | Particules contenant des agents colorants et procedes pour les utiliser | |
CN102099011A (zh) | 基质载体组合物、方法及用途 | |
US20040161438A1 (en) | Cosmetic preparations comprising active ingredients in microcapsules | |
US20160175229A1 (en) | Microparticles with cyclodextrins having a dual level of encapsulation | |
WO2015032984A1 (fr) | Composition de chitosane | |
KR20200064786A (ko) | 알로에 활성성분을 함유하는 나노입자 및 이를 함유하는 화장료조성물 | |
JP3574719B2 (ja) | キトサン誘導体と、そのキトサン誘導体を含有する化粧料 | |
Das et al. | Ionotropically cross-linked polymeric microparticles for drug delivery | |
Guan et al. | Pharmaceutical Applications of Gum Arabic | |
Mahalekshmi et al. | Recent advancement of nanosponges in pharmaceutical formulation for drug delivery systems | |
BR102021004778A2 (pt) | Sistemas nanoparticulados a partir do polisssacarídeo modificado de anacardium occidentale l. (goma do cajueiro) para o tratamento do hiv pediátrico | |
KR20220077460A (ko) | 마사지 장치용 화장품 조성물 | |
JP2022159130A (ja) | 粉末組成物及び用時混合化粧料 | |
Anish | Preparation and in Vitro Evaluation of Griseofulvin Microparticles Using Chitosan and Ethyl Cellulose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD2A | A request for search or an international type search has been filed | ||
TD | Modifications of names of proprietors of patents |
Owner name: ENGELHARD LYON Effective date: 20060403 |
|
MM | Lapsed because of non-payment of the annual fee |
Effective date: 20180801 |